Does increased fatty acid oxidation enhance development of liver cirrhosis and progression to hepatocellular carcinoma in patients with glycogen storage disease type-III?
Herrema
Hilde
H
Smit
G Peter A
GP
Reijngoud
Dirk-Jan
DJ
Kuipers
Folkert
F
D006528:Carcinoma, Hepatocellular / Q000209:etiology*; D018450:Disease Progression; D005227:Fatty Acids / Q000378:metabolism*; D006010:Glycogen Storage Disease Type III / Q000150:complications* / Q000378:metabolism*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications* / Q000209:etiology* / Q000503:physiopathology; D008113:Liver Neoplasms / Q000209:etiology*; D010084:Oxidation-Reduction
D005227:Fatty Acids